Agarwal, V. &
Joseph, B. (2005). Non-union
in osteogenesis imperfecta.
Journal of Pediatric Orthopaedics 14(6):451-455.
[Case Reports. Journal Article]
Aubin I., Adams C.P.,
Opsahl S., Septier D., Bishop C.E., Auge N., Salvayre R.,
Negre-Salvayre A., Goldberg M., Guenet J.L. & Poirier
C. (2005). A
deletion in the gene encoding sphingomyelin
phosphodiesterase 3 (Smpd3) results in osteogenesis and
dentinogenesis imperfecta in the
mouse. Nature
Genetics. 37(8):803-5. [Journal
Article]
Baroncelli, G.I.,
Bertelloni, S., Sodini, F. & Saggese, G. (2005).
Osteoporosis
in Children and Adolescents: Etiology and
Management.
Pediatric Drugs. 7(5):295-323.
[Review]
Cho F.N., Kan Y.Y., Chen
S.N., Yang T.L. & Hsu P.H. (2005).
Osteogenesis
imperfecta associated with first-trimester
ventriculomegaly as an early ultrasound
sign. Prenatal
Diagnosis. 25(6):519-20. [Case Reports.
Letter]
Cho T.J.. Choi I.H.,
Chung C.Y., Yoo W.J., Park M.S. & Park Y.K.
Efficacy
of Oral Alendronate in Children With Osteogenesis
Imperfecta.
Journal of Pediatric Orthopedics. 25(5):607-12.
[Clinical Trial. Journal Article]
Coutouly X., Bibi R.
& Magni C. (2005). [French]
Isolated
basilar artery dissection in a case of osteogenesis
imperfecta. Journal
de Radiologie. 86(1):86-8. [Case Reports. Journal
Article]
Devalia K.L., Mehta R.
& Yagnik M.G. (2005). Use
of maternal bone grafting for long standing segmental gap
non-union in Osteogenesis Imperfecta: a case report with
review of literature.
Injury. 36(9):1130-4. [Review] [15
refs] [Case Reports. Journal Article. Review]
Dimeglio L.A., Ford L.,
McClintock C. & Peacock M. (2005).
A
comparison of oral and intravenous bisphosphonate therapy
for children with osteogenesis imperfecta.
Journal of
Pediatric Endocrinology. 18(1):43-53. [Clinical
Trial. Journal Article. Randomized Controlled Trial]
Fassier, F., Duval, P.
& Dujovne, A. (2005). A
New Telescopic Femur Nail for the Treatment of
Osteogenesis Imperfecta. Journal
of Bone & Joint Surgery - British Volume. 87-B
Supplement II:101
Fleming
F., Woodhead H.J., Briody J.N., Hall J., Cowell C.T.,
Ault J., Kozlowski K. & Sillence, D.O. (2005).
Cyclic
bisphosphonate therapy in osteogenesis imperfecta type
V.
Journal of Paediatrics & Child Health.
41(3):147-151. [Case Reports]
Forin V. (2005).
[French] Osteogenesis
imperfecta and
bisphosphonates.
Archives de Pediatrie. 12(6):688-90. [Journal
Article]
Forin V., Arabi A.,
Guigonis V., Filipe G., Bensman A. & Roux C. (2005).
Benefits
of pamidronate in children with osteogenesis imperfecta:
an open prospective study.
Joint, Bone, Spine: Revue du Rhumatisme.
72(4):313-8. [Journal Article]
Galicka A., Surazynski
A., Wolczynski S., Palka J., Popko J. & Gindzienski
A. (2005). Phenotype
variability in a daughter and father with mild
osteogenesis imperfecta correlated with collagen and
prolidase levels in cultured skin
fibroblasts.
Annals of Clinical Biochemistry. 42(Pt 1):80-4.
[Case Reports. Journal Article]
Gatti D., Antoniazzi F.,
Prizzi R., Braga V., Rossini M., Tato L., Viapiana O.
& Adami S. (2005). Intravenous
neridronate in children with osteogenesis imperfecta: a
randomized controlled study.
Journal of Bone
& Mineral Research. 20(5):758-63. [Clinical
Trial. Journal Article. Randomized Controlled
Trial]
Gatti D., Viapiana O.,
Lippolis I., Braga V., Prizzi R., Rossini M. & Adami
S. (2005). Intravenous
bisphosphonate therapy increases radial width in adults
with osteogenesis
imperfecta.
Journal of Bone & Mineral Research.
20(8):1323-6. [Clinical Trial. Journal Article.
Randomized Controlled Trial]
George, J.A., Basu, D.
& Pettifor, J.M. (2005).
A
Trial of Bisphosphonates in the Management of
Osteogenesis Imperfecta in
Children. Journal
of Bone & Joint Surgery - British Volume. 87-B
Supplement III:273.
Gordon, C.M. (2006).
Evaluation
of bone density in children.
Current Opinion in
Endocrinology & Diabetes. 12(6):444-451.
[Journal Article]
Griffin, D., Hall, C.,
Weisz, B. & Chitty, L.S. (2005).
Sonographic
diagnosis of Osteogenesis Imperfecta types IIB, III and
IV: P03.18.
Ultrasound in Obstetrics & Gynecology. Special
Issue: 15th World Congress on Ultrasound in Obstetrics
and Gynecology. 26(4):392-393.
Gwynne-Jones, D.P.
(2005). Displaced
Olecranon Apophyseal Fractures in Children With
Osteogenesis Imperfecta.
Journal of Pediatric Orthopaedics. 25(2):154-157.
Joseph, B., Rebello, G.
& Chandra K.B. (2005). The
choice of intramedullary devices for the femur and the
tibia in osteogenesis
imperfecta.
Journal of Pediatric Orthopaedics B.
14(5):311-319.
King D., Jarjoura D.,
McEwen H.A. & Askew M.J. (2005).
Growth
hormone injections improve bone quality in a mouse model
of osteogenesis imperfecta.
Journal of Bone & Mineral Research. 20(6):987-93.
[Journal Article]
Le Blanc, K.,
Gotherstrom, C., Ringden, O., Hassan, M., McMahon, R.,
Horwitz, E., Anneren, G., Axelsson, O., Nunn, J., Ewald,
U., Norden-Lindeberg, S., Jansson, M., Dalton, A.,
Astrom, E. & Westgren, M.,
Fetal
Mesenchymal Stem-Cell Engraftment in Bone after In Utero
Transplantation in a Patient with Severe Osteogenesis
Imperfecta.
Transplantation. 79(11):1607-1614.
Letocha A.D., Cintas
H.L., Troendle J.F., Reynolds J.C., Cann C.E., Chernoff
E.J., Hill S.C., Gerber L.H. & Marini J.C. (2005).
Controlled
trial of pamidronate in children with types III and IV
osteogenesis imperfecta confirms vertebral gains but not
short-term functional
improvement.
Journal of Bone & Mineral Research. 20(6):977-86.
[Clinical Trial. Journal Article. Randomized
Controlled Trial]
McKiernan F.E. (2005).
Musculoskeletal
manifestations of mild osteogenesis imperfecta in the
adult.
Osteoporosis International. 16(12):1698-702.
[Journal Article]
Millington-Ward S.,
McMahon H.P. & Farrar G.J. (2005).
Emerging
therapeutic approaches for osteogenesis imperfecta.
Trends in
Molecular Medicine. 11(6):299-305. [Review]
[69 refs] [Journal Article.
Review]
Misof B.M., Roschger P.,
Baldini T., Raggio C.L., Zraick V., Root L., Boskey A.L.,
Klaushofer K., Fratzl P. & Camacho N.P. (2005).
Differential
effects of alendronate treatment on bone from growing
osteogenesis imperfecta and wild-type
mouse. Bone.
36(1):150-8. [Journal Article]
Munns C.F., Rauch F.,
Travers R. & Glorieux F.H. (2005).
Effects
of intravenous pamidronate treatment in infants with
osteogenesis imperfecta: clinical and histomorphometric
outcome. Journal
of Bone & Mineral Research. 20(7):1235-43.
[Clinical Trial. Controlled Clinical Trial. Journal
Article]
Nwosu B.U., Raygada M.,
Tsilou E.T., Rennert O.M. & Stratakis C.A. (2005).
Rieger's
anomaly and other ocular abnormalities in association
with osteogenesis imperfecta and a COL1A1
mutation.
Ophthalmic Genetics. 26(3):135-8. [Case
Reports. Journal Article]
Ozturk H., Oztemur Z.,
Bulut O. & Unsaldi T. (2005).
Complication
following intramedullary fixation with a Fixion nail in a
patient with osteogenesis imperfecta: a case
report. Acta
Orthopaedica Belgica. 71(2):227-9. [Case Reports.
Journal Article]
Pennington, V.J., Zwi,
K.J., Zordan, R.D., Tzioumi, D., O'Meara, M. & Moran,
K. (2005). Child
protection assessment for all infants presenting with
fractures: Evaluation of a Universal Referral Policy.
Journal of
Paediatrics & Child Health. 41(8):S10.
Pizones, J., Plotkin, H.,
Parra-Garcia, J.I., Alvarez, P., Gutierrez, P., Bueno, A.
& Fernandez-Arroyo, A. (2005).
Bone
Healing in Children With Osteogenesis Imperfecta Treated
With Bisphosphonates.
Journal of Pediatric Orthopaedics.
25(3):332-335.
Pochampally, R.R.,
Horwitz, E.M., DiGirolamo, C.M., Stokes, D.S. &
Prockop, D.J. (2005). Correction
of a mineralization defect by overexpression of a
wild-type cDNA for COL1A1 in marrow stromal cells (MSCs)
from a patient with osteogenesis imperfecta: a strategy
for rescuing mutations that produce dominant-negative
protein defects. Gene
Therapy. 12(14):1119-1125. [Journal
Article]
Radkowski C.A., Fitch
R.D. & Hardaker W.T Jr. (2005).
Arthroscopic-assisted
revision of telescopic rods in osteogenesis
imperfecta.
Arthroscopy. 21(1):93-7. [Case Reports.
Journal Article]
Rauch F. & Glorieux
F.H. (2005). Bisphosphonate
treatment in osteogenesis imperfecta: which drug, for
whom, for how long?
Annals of Medicine. 37(4):295-302.
[Review] [46 refs] [Journal Article.
Review]
Rauch F., Land C.,
Cornibert S., Schoenau E. & Glorieux F.H. (2005).
High
and low density in the same bone: a study on children and
adolescents with mild osteogenesis
imperfecta.
Bone. 37(5):634-41. [Journal
Article]
Reis F.C., Alexandrino
F., Steiner C.E., Norato D.Y., Cavalcanti D.P. &
Sartorato E.L. (2005). Molecular
findings in Brazilian patients with osteogenesis
imperfecta. Journal
of Applied Genetics. 46(1):105-8. [Journal
Article]
Saganelidze KhZ.(2005).
[Russian] Role
of the bone mineral density investigation through
measuring of peripheral dual-energetic x-ray absorption
in prevention of fractures in children with osteogenesis
imperfecta.
Georgian Medical News. (3):61-4. [Journal
Article]
Sanches K., de Queiroz
A.M., de Freitas A.C. & Serrano K.V. (2005).
Clinical
features, dental findings and dental care management in
osteogenesis imperfecta. Journal
of Clinical Pediatric Dentistry. 30(1):77-82.
[Case Reports. Journal Article]
Sarathchandra P. &
Pope F.M. Unexpected
ultrastructral changes in bone osteiod collagens in
osteogenesis imperfecta.
Micron. 36(7-8):696-702. [Journal
Article]
Seikaly, M.G., Kopanati,
S., Salhab, N., Waber, P., Patterson, D., Browne, R.
& Herring, J.A. (2005). Impact
of Alendronate on Quality of Life in Children With
Osteogenesis Imperfecta.
Journal of Pediatric Orthopaedics. 25(6):786-791.
[Journal Article. Randomized Controlled
Trial]
Senthilnathan, S.,
Walker, E., Cousins, R., Silverwood, B. & Bishop,
N.J. (2005). G142
Pamidronate for Infants with Osteogenesis Imperfecta:
Comparison of Different Doses.
Archives of
Disease in Childhood. 90 Supplement
II:A58.
Stone J.D. & Wright
T.W. (2005).
Posterior shoulder fracture dislocation in an
osteogenesis imperfecta
patient.
Orthopedics. 28(11):1368-70. [Case Reports.
Journal Article]
Streubel, S-O. &
Lustig, L. (2005). Cochlear
implantation in patients with osteogenesis imperfecta.
Otolaryngology -
Head & Neck Surgery. 132(5):735-740.
Sulko J. & Radlo W.
(2005). [Polish] Operative
management of long-bone of the upper limb in children
with osteogenesis imperfecta.
Chirurgia Narzadow
Ruchu i Ortopedia Polska. 70(3):195-9. [Journal
Article]
Sulko J. & Radlo W.
(2005). [Polish] Osteogenesis
imperfecta--operative treatment on lower extremities in
children with osteogenesis
imperfecta.
Chirurgia Narzadow Ruchu i Ortopedia Polska.
70(3):189-93. [Journal Article]
Tanaka H. (2005).
[Japanese] Bone
quality in osteogenesis
imperfecta.
Clinical Calcium. 15(6):985-9. [Journal
Article]
Theunissen, B. &
Dix-Peek, S. (2005). Differential
Diagnosis of Nonaccidential Injury V Osteogensis
Imperfecta in Small
Children. Journal
of Bone & Joint Surgery - British Volume. 87-B
Supplement I:13.
Unal E., Abaci A., Bober
E. & Buyukgebiz A. (2005).
Oral
alendronate in osteogenesis
imperfecta. Indian
Pediatrics. 42(11):1158-60. [Case Reports.
Journal Article]
Vincent, R., Gratacap,
B., Oates, J. & Sperling, N.M. (2005).
Stapedotomy
in Osteogenesis Imperfecta: A Prospective Study of 23
Consecutive Cases.
Otology & Neurotology.
26(5):859-865.
Vyskocil V., Pikner R.
& Kutilek S. (2005). Effect
of alendronate therapy in children with osteogenesis
imperfecta. Joint,
Bone, Spine: Revue du Rhumatisme. 72(5):416-23.
[Journal Article]
Waltimo-Siren J., Kolkka
M., Pynnonen S., Kuurila K., Kaitila I. & Kovero O.
(2005). Craniofacial
features in osteogenesis imperfecta: a cephalometric
study. American
Journal of Medical Genetics. Part A. 133(2):142-50.
[Journal Article]
Ward, L.M., Denker, A.E.,
Porras, A., Shugarts, S., Kline, W., Travers, R., Mao,
C., Rauch, F., Maes, A., Larson, P., Deutsch, P. &
Glorieux, F.H. (2005). Single-Dose
Pharmacokinetics and Tolerability of Alendronate 35- and
70-Milligram Tablets in Children and Adolescents with
Osteogenesis Imperfecta Type I.
Journal of
Clinical Endocrinology & Metabolism.
90(7):4051-4056. [Clinical Trial. Journal Article.
Randomized Controlled Trial]
Zack P., Franck L.,
Devile C. & Clark C. (2005).
Fracture
and non-fracture pain in children with osteogenesis
imperfecta. Acta
Paediatrica. 94(9):1238-42. [Journal
Article]
